Bibliographical noteFunding Information:
From the Section of General Internal Medicine, Department of Medicine, Minneo olis VA Medical Center and the University of Minnesota School o P Medicme, Mrnneapolis, Minnesota; Section of Lipid Metabolism and Department of Medicine, Boston VA Medical Center and Boston University School of Medicine, Boston, Massachusetts; and the Department of Veterans Affairs Cooperative Studies Coordinating Center, West Haven, Connecticut. The VA HDL Intervention Trial is funded bv the Deoartment of Veterans Affairs Coooerative Studies Program ind a grdnt from the ParkeDavis Group, Division of Warner Lambert Company, Morris Plains, New Jersey. Dr. Rubins’s address is: Section of General Internal Medicine j 1 1 lo), VAMedical Center, Minneapolis, Minnesota 55417. Manuscript received January 10, 1996; revised manuscript received and accepted March 18, 1996. *See appendix for full list of study participants.
From the Department of Cardiological Sciences, St. George’s Hospital Medical School, London, England. This study was supported in pari by the Wellcome Trust and the European Society of Cardiology. Dr. Malik’s address is: De artment of Cardiological Sciences, St. George’s Hospital Medica P School, London, SW1 7 ORE, England. Manuscript received Jonuary 15, 1996; revised manuscript received and accepted March 2 1, 1996.
Copyright 2017 Elsevier B.V., All rights reserved.